cisplatin

SNPwatch: Genetic Variations May Impact Risk of Hearing Loss in Children Receiving Common Chemotherapy Drug

November 10, 2009
Cisplatin, a cancer chemotherapy drug first approved by the FDA in 1978, revolutionized the treatment of many types of cancer.   Despite its effectiveness, in many cases doctors are forced...
Read More